Botanix Pharmaceuticals Limited
BXPHF
$0.04
$0.0010.88%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.32% | 211.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.32% | 211.52% | |||
| Cost of Revenue | 0.32% | 137.51% | |||
| Gross Profit | 0.32% | 278.11% | |||
| SG&A Expenses | 0.32% | -16.62% | |||
| Depreciation & Amortization | 0.31% | 5.75% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.32% | -9.16% | |||
| Operating Income | -0.32% | 32.60% | |||
| Income Before Tax | -0.32% | 38.92% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.32% | 38.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.32% | 38.92% | |||
| EBIT | -0.32% | 32.60% | |||
| EBITDA | -0.32% | 33.48% | |||
| EPS Basic | 0.00% | 42.11% | |||
| Normalized Basic EPS | 0.00% | 40.68% | |||
| EPS Diluted | 0.00% | 42.11% | |||
| Normalized Diluted EPS | 0.00% | 40.68% | |||
| Average Basic Shares Outstanding | 0.00% | 4.87% | |||
| Average Diluted Shares Outstanding | 0.00% | 4.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||